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Intraarterial or intravenous heparinization during neuroin-
terventional procedures has been used regularly for over
30 years. Heparin is administered either as a single bolus,
or continuously intravenously, and/or continuously via
saline flushing of the catheter. Thromboembolism was and
is until today the most common complication resulting in
neurological deficits during neurointerventions. The tech-
nical advances and the continuously increasing number of
neurointerventions have significantly shortened the proce-
dures’ duration. Interventions that last many hours belong
to the past and have become very rare. Additionally, to the
benefit of time reduction, managing of anticoagulation and
antiaggregation treatment has improved. As a result, many
elective interventions are performed under controlled pla-
telet inhibition. Furthermore, emergency treated patients
are not seldom taking anticoagulants or antiplatelets.
Therefore, the role of intraprocedural heparin application
must be reconsidered—not least under the aspect that there
are no standards for heparinization.
Benaly et al. [1] analyzed the Mr Clean data with
regards to the effect of heparin on bleeding rates and out-
come. Of course, there are no national or international
recommendations regarding the use of heparinized flushing
fluid during endovascular interventions and especially in
thrombectomy (EVT) for acute ischemic stroke (AIS).
Therefore, the manuscript raises a very important
question:How much heparin is necessary and how much
heparin is dangerous? The data analysis only shows a trend
without a level of significance. Nevertheless, it is
interesting that the group with 25.000 heparin units stands
out in comparison to the other groups in the following
points: second lowest recanalization rate, highest mortality
rate, highest rate of using stent retriever, fastest manage-
ment with onset to groin puncture, longest procedure time
with probably the highest amount of heparinized infusion,
highest rate of previous anticoagulated patients. The
influence of all these factors certainly determines the
results.
However, this is an important observational study that
clearly shows that little or no administration of heparin
does not lead to more complications and, as a trend, to less
symptomatic bleeding.
What can we learn for our daily practice? Flushing of
the catheter systems might be more important than using
heparin in the flushing fluid, especially in EVT and addi-
tional use of fibrinolytics. The main problem, however, is
that when Heparin is administered via saline flushing, there
is no adequate dose monitoring of the heparin effect. Our
own daily practice does not include heparin in saline
flushing, neither in elective nor in emergency procedures.
Heparin is usually administered as a bolus of 5.000 units,
but not in stroke patients with EVT and not if the expected
duration of the procedure is less than 60 min. However, in
case of venous interventions heparinization is always used.
Keep in mind that thromboembolic complications are
treated very effectively with intravenously application of
GP IIb/IIIa inhibitors.
Is there a need for a randomized trial to get evidence? Is
there a need for standardization? The first question cannot
be answered because heparin administration without a clear
dose plan versus no heparin cannot be examined. The
second question seems to be easier at first glance.
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However, standards also mean that failure to comply could
have legal consequences.
My personal recommendation is: The administration of
heparin during neurointerventional procedures should be
weighed against a specific risk of bleeding. This includes
accompanying medication, duration and type of procedure.
Heparin should be avoided in patients with anticoagulants
or fibrinolytic treatment. When heparin is administered, the
exact amount must be documented. As always, it is a
personal experience from a high volume center and there is
a lack of scientific evidence.
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